It has been another good financial first-half for Beximco Pharmaceuticals, the fast-growing Bangladeshi generics manufacturer, which at the start of its current financial year ending June 2020 added a fifth offering to its product range in the key US market as it pursues its aim of being a major global player.
Dhaka-based Beximco Pharma reported profit after tax that soared by 16.7% to BDT1.735bn ($20.4m) in its financial first-half ended December...






